These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 18300768)

  • 1. The MAPK pathway in melanoma.
    Fecher LA; Amaravadi RK; Flaherty KT
    Curr Opin Oncol; 2008 Mar; 20(2):183-9. PubMed ID: 18300768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the mitogen-activated protein kinase pathway in the treatment of malignant melanoma.
    Panka DJ; Atkins MB; Mier JW
    Clin Cancer Res; 2006 Apr; 12(7 Pt 2):2371s-2375s. PubMed ID: 16609061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in targeted therapy for melanoma.
    Friedlander P; Hodi FS
    Clin Adv Hematol Oncol; 2010 Sep; 8(9):619-27. PubMed ID: 21157411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New therapies targeting the genetic mutations responsible for different types of melanoma].
    Botella-Estrada R; Sanmartín Jiménez O
    Actas Dermosifiliogr; 2010 Jun; 101(5):394-400. PubMed ID: 20525481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular cytogenetics of cutaneous melanocytic lesions - diagnostic, prognostic and therapeutic aspects.
    Blokx WA; van Dijk MC; Ruiter DJ
    Histopathology; 2010 Jan; 56(1):121-32. PubMed ID: 20055910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of mitogen- and stress-activated protein kinase pathways in melanoma.
    Lopez-Bergami P
    Pigment Cell Melanoma Res; 2011 Oct; 24(5):902-21. PubMed ID: 21914141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trametinib (GSK1120212) in the treatment of melanoma.
    Salama AK; Kim KB
    Expert Opin Pharmacother; 2013 Apr; 14(5):619-27. PubMed ID: 23432625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histologic and epidemiologic correlates of P-MAPK, Brn-2, pRb, p53, and p16 immunostaining in cutaneous melanomas.
    Richmond-Sinclair NM; Lee E; Cummings MC; Williamson R; Muller K; Green AC; Hayward NK; Whiteman DC
    Melanoma Res; 2008 Oct; 18(5):336-45. PubMed ID: 18781132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic alterations in signaling pathways in melanoma.
    Haluska FG; Tsao H; Wu H; Haluska FS; Lazar A; Goel V
    Clin Cancer Res; 2006 Apr; 12(7 Pt 2):2301s-2307s. PubMed ID: 16609049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining nanoliposomal ceramide with sorafenib synergistically inhibits melanoma and breast cancer cell survival to decrease tumor development.
    Tran MA; Smith CD; Kester M; Robertson GP
    Clin Cancer Res; 2008 Jun; 14(11):3571-81. PubMed ID: 18519791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular targeted therapy for patients with melanoma: the promise of MAPK pathway inhibition and beyond.
    Sullivan RJ; Atkins MB
    Expert Opin Investig Drugs; 2010 Oct; 19(10):1205-16. PubMed ID: 20687784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scaffold proteins in MAP kinase signaling: more than simple passive activating platforms.
    Dard N; Peter M
    Bioessays; 2006 Feb; 28(2):146-56. PubMed ID: 16435292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rho/ROCK and MAPK signaling pathways are involved in glioblastoma cell migration and proliferation.
    Zohrabian VM; Forzani B; Chau Z; Murali R; Jhanwar-Uniyal M
    Anticancer Res; 2009 Jan; 29(1):119-23. PubMed ID: 19331140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
    Yang R; Piperdi S; Gorlick R
    Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders.
    Aoki Y; Niihori T; Narumi Y; Kure S; Matsubara Y
    Hum Mutat; 2008 Aug; 29(8):992-1006. PubMed ID: 18470943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor-alpha up-regulates the expression of CCL2 and adhesion molecules of human proximal tubular epithelial cells through MAPK signaling pathways.
    Ho AW; Wong CK; Lam CW
    Immunobiology; 2008; 213(7):533-44. PubMed ID: 18656701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori and mitogen-activated protein kinases regulate the cell cycle, proliferation and apoptosis in gastric epithelial cells.
    Ding SZ; Smith MF; Goldberg JB
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e67-78. PubMed ID: 18702686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetic markers of melanoma].
    Tronov VA; Artamonov DN; Gorbacheva LB
    Genetika; 2010 Feb; 46(2):168-79. PubMed ID: 20297650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular genetic diagnostics in syndromes associated with the RAS/MAPK signalling pathway].
    Molven A; Søvik O; von der Lippe C; Steine SJ; Njølstad PR; Houge G; Prescott TE
    Tidsskr Nor Laegeforen; 2009 Nov; 129(22):2358-61. PubMed ID: 19935936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Src-p38 mitogen-activated protein kinase signaling is required for Akt activation in response to ionizing radiation.
    Kim MJ; Byun JY; Yun CH; Park IC; Lee KH; Lee SJ
    Mol Cancer Res; 2008 Dec; 6(12):1872-80. PubMed ID: 19074832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.